TE_8327
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_B |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | -, FHIT |
| Class | Chimeric, Intergenic |
| Coding | Annoated, Non-coding |
| Tumor-specific score | 160.05 |
| Counts of samples | TCGA_tumor:141; TCGA_normal:0; GTEx:0 |
| TSS | chr3(-):61435007 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_8327.1 | - | Intergenic | Non-coding | Non-coding | chr3(-):61425854,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.2 | - | Intergenic | Non-coding | Non-coding | chr3(-):61428615,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.3 | - | Intergenic | Non-coding | Non-coding | chr3(-):61427666,61427686,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.4 | - | Intergenic | Non-coding | Non-coding | chr3(-):61405485,61405505,61425745,61425874,61429160,61429307,61434924,61435008 |
| teRNA_8327.5 | - | Intergenic | Non-coding | Non-coding | chr3(-):61383295,61383315,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.6 | - | Intergenic | Non-coding | Non-coding | chr3(-):61400931,61400951,61405453,61405505,61425745,61425874,61427573,61427686,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.7 | - | Intergenic | Non-coding | Non-coding | chr3(-):61320064,61320084,61405453,61405505,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.8 | - | Intergenic | Non-coding | Non-coding | chr3(-):61400931,61400951,61405453,61405505,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.9 | - | Intergenic | Non-coding | Non-coding | chr3(-):61357719,61357739,61405453,61405505,61425745,61425874,61427573,61427686,61428514,61428635,61429160,61429307,61434924,61435008 |
| teRNA_8327.10 | FHIT | Chimeric | Annoated | MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTFSMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ* | chr3(-):59749559,59749579,59752221,59752321,59922346,59922414,60011371,60011400,60014007,60014152,60536860,60536979,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
